Buy Like Buffett
Watchlist

Flagship explainer

How PACIRA BIOSCIENCES, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$726M · 100%Cost of revenue$150M · 21%Gross profit$577M · 79%Operating income$19.2M · 3%Income before tax$16.9M · 2%Income tax$9.8M · 1%Net income$7M · 1%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$726M100%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-012297 · filed Feb 26, 2026
Cost of revenue$150M21%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-012297 · filed Feb 26, 2026
$577M79%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-012297 · filed Feb 26, 2026
$19.2M3%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-012297 · filed Feb 26, 2026
Income before tax$16.9M2%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-012297 · filed Feb 26, 2026
Income tax$9.8M1%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-012297 · filed Feb 26, 2026
$7M1%
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-012297 · filed Feb 26, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001628280-26-012297 · filed Feb 26, 2026
· event Dec 31, 2025 · retrieved Oct 17, 2026 · annual-row source set
Embed this chart

View the full PACIRA BIOSCIENCES, INC. analysis at Buy Like Buffett